Subtopic Deep Dive
McDonald Criteria Revisions
Research Guide
What is McDonald Criteria Revisions?
McDonald Criteria Revisions are sequential updates to the diagnostic standards for multiple sclerosis, starting from 2001 with major changes in 2005, 2010, and 2017 to enhance sensitivity and specificity using MRI and clinical evidence.
The 2005 revisions by Polman et al. integrated MRI for dissemination in space and time (Polman et al., 2005, 4963 citations). The 2010 updates by Polman et al. simplified imaging requirements (Polman et al., 2011, 9705 citations). The 2017 revisions by Thompson et al. incorporated CSF-specific oligoclonal bands for primary progressive MS (Thompson et al., 2017, 7511 citations).
Why It Matters
McDonald Criteria revisions standardize MS diagnosis across clinical trials, enabling consistent patient enrollment and outcome measurement worldwide. Polman et al. (2011) revisions improved early diagnosis, accelerating trials like Hauser et al. (2016) ocrelizumab study. Thompson et al. (2017) updates enhanced specificity, reducing misdiagnosis in epidemiological studies like Wallin et al. (2019) US prevalence estimates. These changes directly support reproducible research and treatment development.
Key Research Challenges
Balancing Sensitivity-Specificity
Revisions must increase early detection without false positives. Polman et al. (2005) raised sensitivity via MRI but risked overdiagnosis. Thompson et al. (2017) addressed this with CSF biomarkers.
Incorporating New Biomarkers
Integrating serum neurofilament light and CSF findings remains challenging. Disanto et al. (2017) showed NfL elevation in MS, but criteria lag. Future revisions need validation against Polman et al. (2011) standards.
Adapting to Disease Phenotypes
Criteria must align with clinical courses like relapsing-remitting. Lublin et al. (2014) defined phenotypes, highlighting gaps in progressive MS diagnosis. Thompson et al. (2017) partially resolved this.
Essential Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · 2011 · Annals of Neurology · 9.7K citations
Abstract New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervou...
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson, Brenda Banwell, Frederik Barkhof et al. · 2017 · The Lancet Neurology · 7.5K citations
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Chris H. Polman, Stephen C. Reingold, Gilles Edan et al. · 2005 · Annals of Neurology · 5.0K citations
Abstract New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald Criteria”...
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · 2014 · Neurology · 3.0K citations
Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important for communication, prognostication, design and recruitment of clinical trials, and treatment decision-mak...
Revised diagnostic criteria for neuromyelitis optica
Dean M. Wingerchuk, Vanda A. Lennon, Sean J. Pittock et al. · 2006 · Neurology · 2.6K citations
The authors propose revised diagnostic criteria for definite neuromyelitis optica (NMO) that require optic neuritis, myelitis, and at least two of three supportive criteria: MRI evidence of a conti...
Multiple sclerosis – a review
Ruth Dobson, Gavin Giovannoni · 2018 · European Journal of Neurology · 2.0K citations
Multiple sclerosis ( MS ) is the commonest non‐traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the socioeconomic impact of the disease...
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı et al. · 2016 · New England Journal of Medicine · 1.9K citations
Among patients with relapsing multiple sclerosis, ocrelizumab was associated with lower rates of disease activity and progression than interferon beta-1a over a period of 96 weeks. Larger and longe...
Reading Guide
Foundational Papers
Start with Polman et al. (2005, 4963 citations) for MRI integration baseline, then Polman et al. (2011, 9705 citations) for simplified dissemination rules, followed by Lublin et al. (2014) for phenotype context.
Recent Advances
Study Thompson et al. (2017, 7511 citations) for CSF advancements; Disanto et al. (2017) for NfL biomarker potential; Wallin et al. (2019) for prevalence impacts.
Core Methods
Core techniques: MRI for lesions in space/time (Polman et al., 2011); CSF oligoclonal bands (Thompson et al., 2017); clinical attack verification with paraclinical evidence.
How PapersFlow Helps You Research McDonald Criteria Revisions
Discover & Search
Research Agent uses citationGraph on Polman et al. (2011) to map 9705 citations linking 2005-2017 revisions, then exaSearch for 'McDonald criteria 2023 updates' to find post-Thompson developments. findSimilarPapers on Thompson et al. (2017) reveals 7511-cited impacts on trial design.
Analyze & Verify
Analysis Agent applies readPaperContent to extract MRI dissemination rules from Polman et al. (2011), then verifyResponse with CoVe against Thompson et al. (2017) for revision accuracy. runPythonAnalysis computes sensitivity metrics from extracted data using pandas, with GRADE grading for evidence strength in diagnostic claims.
Synthesize & Write
Synthesis Agent detects gaps like missing NfL integration post-Disanto et al. (2017), flags contradictions between Polman (2005) and Thompson (2017) on CSF. Writing Agent uses latexEditText for criteria comparison tables, latexSyncCitations for 10+ papers, and latexCompile for publication-ready review.
Use Cases
"Compare sensitivity of 2010 vs 2017 McDonald criteria using stats from papers"
Research Agent → searchPapers 'McDonald 2010 2017 sensitivity' → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Polman 2011/Thompson 2017 data) → statistical table output with p-values.
"Draft LaTeX review of McDonald revisions evolution"
Synthesis Agent → gap detection on Polman/Thompson papers → Writing Agent → latexEditText (criteria timeline) → latexSyncCitations (add 5 papers) → latexCompile → PDF with timeline diagram.
"Find code for McDonald MRI lesion segmentation"
Research Agent → searchPapers 'McDonald criteria MRI analysis code' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → validated GitHub repo for lesion volume quantification.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ McDonald papers) → citationGraph → DeepScan (7-step verification with CoVe on revisions) → structured report on evolution. Theorizer generates hypotheses like 'CSF integration post-2017 improves specificity by 15%' from Polman/Thompson data. DeepScan analyzes trial impacts with runPythonAnalysis on Hauser (2016) enrollment criteria.
Frequently Asked Questions
What defines McDonald Criteria Revisions?
Sequential updates (2001 baseline, revised 2005, 2010, 2017) to MS diagnostic standards incorporating MRI dissemination in space/time and CSF oligoclonal bands (Polman et al., 2005; 2011; Thompson et al., 2017).
What methods improved in 2017 revisions?
Thompson et al. (2017) added CSF-specific oligoclonal bands for primary progressive MS diagnosis and simplified asymptomatic lesion requirements, increasing sensitivity over Polman et al. (2011).
What are key papers on McDonald revisions?
Polman et al. (2011, 9705 citations) for 2010 revisions; Thompson et al. (2017, 7511 citations) for 2017; Polman et al. (2005, 4963 citations) for 2005 updates.
What open problems exist in criteria?
Integrating serum NfL biomarkers (Disanto et al., 2017); adapting to phenotypes (Lublin et al., 2014); post-2017 validation in diverse populations (Wallin et al., 2019).
Research Multiple Sclerosis Research Studies with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching McDonald Criteria Revisions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.